Results 11 to 20 of about 27,986 (235)

Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy

open access: yesCancers, 2022
Simple Summary Tumor necrosis factor (TNF) receptor-2 (TNFR2) affects tumor development and metastasis in several ways. TNFR2 promotes tumor immune escape by virtue of its ability to stimulate various immune suppressive cell types, e.g., regulatory T ...
Harald Wajant   +2 more
exaly   +3 more sources

TNF Production or TNFR2 Expression Characterize Distinct States of Regulatory T Cells That Cooperate in Treg Expansion in Cancer and Chronic Inflammation [PDF]

open access: yesEuropean Journal of Immunology
TNF is a pleiotropic cytokine with immunomodulatory functions mediated by its interaction with the receptor TNFR2, highly expressed by Tregs. However, Tregs can also produce TNF, and an autocrine TNF‐TNFR2 loop has been proposed.
Valerio Licursi   +2 more
exaly   +3 more sources

TNFR2: Role in Cancer Immunology and Immunotherapy

open access: yesImmunoTargets and Therapy, 2021
Yang Yang, Md Sahidul Islam, Yuanjia Hu, Xin Chen State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, SAR, 999078, People’s Republic of ChinaCorrespondence: Xin ChenState ...
Yang Y, Islam MS, Hu Y, Chen X
doaj   +4 more sources

TNFR2:Target for therapeutics against neurodegenerative diseases?

open access: yes, 2010
Tumor necrosis factor α (TNFα) is a proinflammatory cytokine which acts via its two receptors TNFR1 and TNFR2. It is involved in many cell types in various cellular functions of cell growth, differentiation, and cellular apoptosis.
Eisel, Ulrich L. M.; id_orcid   +8 more
core   +5 more sources

Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors

open access: yesCells, 2021
Triple-negative breast cancer (TNBC) is primarily treated via chemotherapy; in parallel, efforts are made to introduce immunotherapies into TNBC treatment. CD4+ TNFR2+ lymphocytes were reported as Tregs that contribute to tumor progression.
Tamir Baram   +9 more
doaj   +2 more sources

Abstract 2136: Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies

open access: yesCancer Research, 2017
Background: Although antibody targeting of the HER2 oncogene represents an outstanding clinical treatment and a success story showing direct cancer killing with antibodies, many oncogenes are intracellular and are not expressed broadly, whether on a ...
Rosemary Foster   +12 more
core   +2 more sources

TNFR2: The new Treg switch? [PDF]

open access: yesOncoImmunology, 2018
Three recent publications identified the TNF/TNR2 pathway as a new target to reduce graft-versus-host-disease through regulatory T cells activation or to potentially switch on a strong anti-leukemic effect through regulatory T cells blockade in ...
José L. Cohen, Kathryn J. Wood
doaj   +4 more sources

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling

open access: yesFrontiers in Cell and Developmental Biology, 2023
Tumor necrosis factor (TNF) receptor 1 (TNFR1), TNFR2 and fibroblast growth factor-inducible 14 (Fn14) belong to the TNF receptor superfamily (TNFRSF). From a structural point of view, TNFR1 is a prototypic death domain (DD)-containing receptor.
D. Siegmund, O.Ye. Zaitseva, H. Wajant
semanticscholar   +5 more sources

Leukocyte TNFR1 and TNFR2 Expression Contributes to the Peripheral Immune Response in Cases with Ischemic Stroke [PDF]

open access: yesCells, 2021
Tumor necrosis factor receptor 1 and 2 (TNFR1 and TNFR2) have been found in brain parenchyma of stroke patients, and plasma levels are increased in the acute phase of stroke.
Rikke B. Hansen   +8 more
doaj   +2 more sources

Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion

open access: yesJournal for ImmunoTherapy of Cancer
Background Although tumor necrosis factor receptor 2 (TNFR2) has been recognized as an attractive next-generation candidate target for cancer immunotherapy, the factors that regulate the gene expression and their mechanistic effects on tumor-infiltrating
Yao Liu   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy